Lipid lowering therapy and stabilization of atherosclerotic plaques

Area of Science:

• Cardiovascular Medicine
• Atherosclerosis Research
• Lipid Metabolism

Background:

• Current lipid-lowering therapies significantly reduce cardiovascular complications.
• However, these therapies show minimal impact on the degree of coronary artery stenosis.

Purpose of the Study:

• To explore the new paradigm of coronary artery disease (CAD) where prognosis depends on plaque characteristics.
• To investigate the role of plaque structure and number in determining clinical outcomes.

Main Methods:

• Review of existing studies on lipid-lowering therapy and coronary artery disease.
• Analysis of atherosclerotic plaque characteristics, including lipid core, inflammatory cells, and fibrous cap thickness.
• Evaluation of the impact of plaque rupture on acute coronary syndromes.

Main Results:

• Clinical prognosis in CAD is primarily determined by the number and structure of atherosclerotic plaques.
• Vulnerable plaques, defined by specific features, are prone to rupture, leading to thrombus formation and acute coronary syndromes.
• Cholesterol lowering shows potential for plaque stabilization and improving endothelial function.

Conclusions:

• A shift in understanding CAD is necessary, focusing on plaque vulnerability rather than solely stenosis degree.
• Lipid-lowering interventions may offer benefits beyond stenosis reduction by stabilizing plaques.
• Further research into plaque stabilization mechanisms is crucial for managing acute coronary syndromes.